TNF and atherosclerosis: As for animal models of atherosclerosis, Melgar-Lesmes et al [41] observed that in mice receiving CS, this component directly latches onto the atheromatous plaque, drastically reducing its size, recedes TNF effects, heals endothelial injury, and decreases the monocyte/macrophage differentiation into foam cells.